News and commentary on IP issues

Patent Sufficiency reconsidered by UK Court of Appeal

This Court of Appeal Decision concerned two families of patents held by FibroGen:Family A and Family B relating to H1F-PH inhibitors for the treatment of (respectively) CKD anaemia (anaemia associated with chronic kidney disease) and ACD (anaemia of chronic disease).Family A was published before the relevant priority date of Family B, and so i...
Continue reading
  2281 Hits
2281 Hits